Nathan Watson

770 total citations
29 papers, 544 citations indexed

About

Nathan Watson is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Nathan Watson has authored 29 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 6 papers in Cardiology and Cardiovascular Medicine and 5 papers in Surgery. Recurrent topics in Nathan Watson's work include Venous Thromboembolism Diagnosis and Management (5 papers), Hearing, Cochlea, Tinnitus, Genetics (4 papers) and Hearing Loss and Rehabilitation (4 papers). Nathan Watson is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (5 papers), Hearing, Cochlea, Tinnitus, Genetics (4 papers) and Hearing Loss and Rehabilitation (4 papers). Nathan Watson collaborates with scholars based in United States, Japan and China. Nathan Watson's co-authors include Xiaoxia Zhu, Bo Ding, Robert D. Frisina, Cesar V. Borlongan, Hanny Al‐Samkari, Mia C. Borlongan, Daniel Y. Joh, Nicholas X. Williams, Ashutosh Chilkoti and Aaron D. Franklin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Circulation.

In The Last Decade

Nathan Watson

23 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nathan Watson United States 10 104 102 98 85 84 29 544
Qing Yin China 18 421 4.0× 152 1.5× 58 0.6× 129 1.5× 95 1.1× 51 1.2k
Bernhard G. Weiss Germany 16 124 1.2× 17 0.2× 116 1.2× 80 0.9× 96 1.1× 71 836
Stephen C. Helps Australia 17 212 2.0× 126 1.2× 32 0.3× 177 2.1× 41 0.5× 22 669
M.T. Magalhães‐Cardoso Portugal 16 224 2.2× 42 0.4× 23 0.2× 88 1.0× 41 0.5× 27 740
Francisco Santaolalla Spain 16 116 1.1× 22 0.2× 100 1.0× 46 0.5× 120 1.4× 47 584
Xiangfu Zhou China 18 162 1.6× 20 0.2× 25 0.3× 69 0.8× 146 1.7× 47 793
Hongliang Zheng China 19 269 2.6× 22 0.2× 129 1.3× 95 1.1× 337 4.0× 104 1.1k
Bernhard Olzowy Germany 13 33 0.3× 23 0.2× 198 2.0× 190 2.2× 130 1.5× 33 529
Hyun Woo Lim South Korea 15 83 0.8× 29 0.3× 244 2.5× 205 2.4× 61 0.7× 53 659
Maria Luisa Rocco Italy 14 272 2.6× 37 0.4× 16 0.2× 94 1.1× 31 0.4× 23 930

Countries citing papers authored by Nathan Watson

Since Specialization
Citations

This map shows the geographic impact of Nathan Watson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan Watson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan Watson more than expected).

Fields of papers citing papers by Nathan Watson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathan Watson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan Watson. The network helps show where Nathan Watson may publish in the future.

Co-authorship network of co-authors of Nathan Watson

This figure shows the co-authorship network connecting the top 25 collaborators of Nathan Watson. A scholar is included among the top collaborators of Nathan Watson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan Watson. Nathan Watson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Watson, Nathan, et al.. (2025). Advancing Health Equity in the Cardiovascular Device Life Cycle. Circulation Cardiovascular Quality and Outcomes. 18(3). e011310–e011310.
2.
McCarthy, Cian P., Nathan Watson, Jason H. Wasfy, et al.. (2025). Cardiac Biomarker Testing in US Emergency Departments. JAMA Internal Medicine. 185(3). 343–343.
3.
Watson, Nathan, Michael R. Jaff, Brett Carroll, et al.. (2025). Temporal Trends and Practice Patterns Associated With Utilization of Catheter-Based Interventions for Pulmonary Embolism. Journal of the Society for Cardiovascular Angiography & Interventions. 4(8). 103736–103736.
4.
Watson, Nathan, Brett Carroll, Anna Krawisz, Alec A. Schmaier, & Eric A. Secemsky. (2024). Trends in Discharge Rates for Acute Pulmonary Embolism in U.S. Emergency Departments. Annals of Internal Medicine. 177(2). 134–143. 9 indexed citations
5.
Watson, Nathan, et al.. (2024). Clinical Outcomes and Predictors of Advanced Therapy for the Management of Right Heart Thrombus. Circulation Cardiovascular Interventions. 17(4). e013637–e013637. 1 indexed citations
6.
Watson, Nathan, David E. Kandzari, Ajay J. Kirtane, et al.. (2024). Abstract 4125667: National Estimates of Patient Eligibility for Renal Denervation Therapy Post-FDA Approval. Circulation. 150(Suppl_1).
7.
Lin, Dong, Nathan Watson, Lothar Esser, et al.. (2023). Structures of Cancer Antigen Mesothelin and Its Complexes with Therapeutic Antibodies. Cancer Research Communications. 3(2). 175–191. 15 indexed citations
8.
Watson, Nathan, Ido Weinberg, Jordan B. Strom, et al.. (2023). Clinical Significance of Right Heart Thrombus With and Without an Associated Pulmonary Embolism. The American Journal of Medicine. 136(11). 1109–1118.e3. 2 indexed citations
9.
Watson, Nathan, Ramya Mosarla, & Eric A. Secemsky. (2023). Endovascular Interventions for Peripheral Artery Disease: A Contemporary Review. Current Cardiology Reports. 25(11). 1611–1622. 6 indexed citations
10.
Watson, Nathan, Joseph J. Shatzel, & Hanny Al‐Samkari. (2023). Cyclin-dependent kinase 4/6 inhibitor-associated thromboembolism: a critical evaluation of the current evidence. Journal of Thrombosis and Haemostasis. 21(4). 758–770. 9 indexed citations
11.
Watson, Nathan & Hanny Al‐Samkari. (2022). Eptacog beta, a novel recombinant factor VIIa, for the treatment of hemophilia. Drugs of today. 58(3). 105–116. 2 indexed citations
12.
Watson, Nathan & Hanny Al‐Samkari. (2021). Thrombotic and bleeding risk of angiogenesis inhibitors in patients with and without malignancy. Journal of Thrombosis and Haemostasis. 19(8). 1852–1863. 36 indexed citations
13.
Watson, Nathan, Seth A. Wander, & Hanny Al‐Samkari. (2021). Venous and Arterial Thrombosis Following Abemaciclib Therapy for Metastatic Breast Cancer. Blood. 138(Supplement 1). 4063–4063. 2 indexed citations
14.
Naples, James G., et al.. (2020). A tale of two tinnituses: Does hearing status influence central tinnitus localization?. Medical Hypotheses. 146. 110444–110444. 2 indexed citations
15.
Williams, Nicholas X., Nathan Watson, Daniel Y. Joh, Ashutosh Chilkoti, & Aaron D. Franklin. (2019). Aerosol jet printing of biological inks by ultrasonic delivery. Biofabrication. 12(2). 25004–25004. 42 indexed citations
16.
Wall, Emily, et al.. (2019). Development of a weighting strategy for a manufacturability assessment. Procedia Computer Science. 153. 309–316. 1 indexed citations
17.
Watson, Nathan, Bo Ding, Xiaoxia Zhu, & Robert D. Frisina. (2017). Chronic inflammation – inflammaging – in the ageing cochlea: A novel target for future presbycusis therapy. Ageing Research Reviews. 40. 142–148. 147 indexed citations
18.
Lippert, Trenton, Nathan Watson, Xunming Ji, et al.. (2016). Detrimental effects of physical inactivity on neurogenesis. SHILAP Revista de lepidopterología. 2(2). 80–85. 6 indexed citations
19.
Acosta, Sandra, et al.. (2015). Enhancing endogenous stem cells in the newborn via delayed umbilical cord clamping. SHILAP Revista de lepidopterología. 10(9). 1359–1359. 24 indexed citations
20.
Watson, Nathan, et al.. (2014). Discarded Wharton jelly of the human umbilical cord: a viable source for mesenchymal stromal cells. Cytotherapy. 17(1). 18–24. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026